{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:53:07Z","timestamp":1786737187267,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.292315","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T02:35:01Z","timestamp":1597890901000},"page":"814","source":"Crossref","is-referenced-by-count":0,"title":["Arterial Hypertension in Systemic Lupus Erythematosus: About 40 Cases"],"prefix":"10.4103","volume":"31","author":[{"given":"Imene","family":"Rachdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Zoubeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Somai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Fekih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BesmaBen","family":"Dhaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Aydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Boussema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.292315-1","doi-asserted-by":"crossref","first-page":"R1258","DOI":"10.1152\/ajpregu.90864.2008","article-title":"The pathophysiology of hypertension in systemic lupus erythematosus","author":"Ryan","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key-10.4103\/1319-2442.292315-2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"key-10.4103\/1319-2442.292315-3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"key-10.4103\/1319-2442.292315-4","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.11260","article-title":"Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy","author":"Sella","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/1319-2442.292315-5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archinte.1976.03630090033009","article-title":"Hypertension and renal disease in systemic lupus erythematosus","author":"Budman","year":"1976","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/1319-2442.292315-6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0049-0172(87)90035-7","article-title":"Cardiovascular involvement in systemic lupus erythematosus","author":"Mandell","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/1319-2442.292315-7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythe- matosus","author":"Magder","year":"2012","journal-title":"Am J Epidemiol"},{"key":"key-10.4103\/1319-2442.292315-8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.101132","article-title":"Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus","author":"Sabio","year":"2011","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10067-014-2802-0","article-title":"Persistent hypertension in lupus nephritis and the associated risk factors","author":"Shaharir","year":"2015","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-10","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1097\/MD.0000000000001183","article-title":"Cardiovascular events in systemic lupus erythematosus: A nationwide study in spain from the RELESSER registry","author":"Fern\u00e1ndez-Nebro","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/1319-2442.292315-11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1319-2442.292315-12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.semarthrit.2013.07.007","article-title":"Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients.a critical appraisal?","author":"Tselios","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.4103\/1319-2442.292315-13","unstructured":"Health, United States. With chartbook on trends in health of Americans. Hyattsville, MD: National Center for Health Statistics; 2007."},{"key":"key-10.4103\/1319-2442.292315-14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","author":"Doria","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1319-2442.292315-15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/096120300678828226","article-title":"Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort","author":"Petri","year":"2000","journal-title":"Lupus"},{"key":"key-10.4103\/1319-2442.292315-16","first-page":"493","article-title":"Cardiovascular risk factor screening in systemic lupus erythematosus","author":"Al-Herz","year":"2003","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.steroids.2010.02.010","article-title":"Can estrogens promote hypertension during systemic lupus erythematosus?","author":"Venegas-Pont","year":"2010","journal-title":"Steroids"},{"key":"key-10.4103\/1319-2442.292315-18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2006.059311","article-title":"African-American and hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: Results from LUMINA, a multiethnic cohort (LUMINAXLV)","author":"Chaiamnuay","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1319-2442.292315-19","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3899\/jrheum.150531","article-title":"Nighttime blood pressure patterns and subclinical atherosclerosis in women with systemic lupus erythematosus","author":"Sabio","year":"2015","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-20","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10067-010-1517-0","article-title":"Analysis of clinical manifestations and pathology of lupus nephritis: A retrospective review of 82 cases","author":"Guo","year":"2010","journal-title":"Clin Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/pgmj.73.858.230","article-title":"The significance of arterial hypertension at the onset of clinical lupus nephritis","author":"Naiker","year":"1997","journal-title":"Postgrad Med J"},{"key":"key-10.4103\/1319-2442.292315-22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1753944716637807","article-title":"Understanding mechanisms of hypertension in systemic lupus erythematosus","author":"Taylor","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"key-10.4103\/1319-2442.292315-23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rdc.2015.08.007","article-title":"Corticosteroids in lupus","author":"Kasturi","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"key-10.4103\/1319-2442.292315-24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1319-2442.292315-25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"key-10.4103\/1319-2442.292315-26","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/rheumatology\/ker285","article-title":"Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus","author":"Kiani","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"key":"key-10.4103\/1319-2442.292315-27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.05.008","article-title":"Cardiovascular disease in systemic lupus erythematosus: A comprehensive update","author":"Giannelou","year":"2017","journal-title":"J Autoimmun"},{"key":"key-10.4103\/1319-2442.292315-28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3899\/jrheum.080373","article-title":"Poor outcomes after acute myocardial infarction in systemic lupus erythematosus","author":"Shah","year":"2009","journal-title":"J Rheumatol"},{"key":"key-10.4103\/1319-2442.292315-29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2009.117200","article-title":"European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","author":"Mosca","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/1319-2442.292315-30","first-page":"1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: Executive summary.Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1319-2442.292315-31","first-page":"1093","article-title":", Vila LM, Reveille JD, Alarcon GS, Cohort Lam U","author":"Duran-Barragan","year":"2008","journal-title":"Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus results from LUMINA (LIX): A multiethnic US cohort, Rheumatol Oxf Engl"},{"key":"key-10.4103\/1319-2442.292315-32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus","author":"Stojan","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"key-10.4103\/1319-2442.292315-33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000183318","article-title":"Captopril treatment of hypertension and renal failure in systemic lupus erythematosus","author":"Herlitz","year":"1984","journal-title":"Nephron"},{"key":"key-10.4103\/1319-2442.292315-34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0003319711432861","article-title":"The association of Raynaud syndrome with \u03b2- blockers: A meta-analysis","author":"Mohokum","year":"2012","journal-title":"Angiology"},{"key":"key-10.4103\/1319-2442.292315-35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keg436","article-title":"Prevention of cardiovascular disease in systemic lupus erythematosus\u2014proposed guidelines for risk factor management","author":"Wajed","year":"2004","journal-title":"Rheumatology"},{"key":"key-10.4103\/1319-2442.292315-36","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","article-title":"Hydroxychloroquine use in the baltimore lupus cohort: Effects on lipids, glucose and thrombosis","author":"Petri","year":"1996","journal-title":"Lupus"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:51:16Z","timestamp":1786733476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.292315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["292315"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.292315","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}